Making data-driven decisions can help reduce your loss potential and increase profit margins.
In this op-ed, Jeff Scheir makes his case against using ozone in cultivating cannabis.
How Would the U.S. Drug Enforcement Administration’s Potential Reclassification of Cannabis Affect Georgia’s Medical Cannabis Industry?
A good community outreach strategy can help boost a company’s brand in front of consumers.
Manufacturers of CBD products should heed Sandler’s advice when marketing their product and engaging in interstate commerce.
Being the first almost never means being the best.
Matt Engle discusses the necessity for insurers to meet the changing coverage requirements of the cannabis industry by offering more options tailored to distributors, growers, processors, and retail dispensaries.
Until federal law clarifies interstate commerce laws pertaining to hemp, producers should reconsider transporting hemp through less-receptive states.
Getting a third-party audit can sound frightening, but with these seven steps you can effectively prepare for any challenges that may arise from your next audit.
Peyton sheds some light on the controversy over the Farm Bill and FDA regulation, suggesting hemp companies do their homework first.